In November 2022, the annual Pharmaceutical Ingredients World (CPHI Worldwide) was successfully held at Messe Frankfurt, Germany. As the world's largest professional exhibition for the pharmaceutical industry, CPHI Worldwide brings together world-class pharmaceutical giants and leading pharmaceutical companies from all over the world, attracting much attention from the industry. During the exhibition, Gan & Lee's international BD team received nearly 500 customers from all over the world and more than 70 meetings at the booth. This exhibition is an important step for the Gan & Lee brand towards the international stage of the pharmaceutical industry.

The 2022 World Diabetes Congress, organized by the International Diabetes Federation (IDF), was smoothly held in December at the Lisbon Convention Center in Portugal, providing a professional knowledge exchange forum for healthcare professionals, advocates and diabetes patients worldwide through a combination of online and offline formats. This time, Gan & Lee Pharmaceuticals appeared at the conference as an exhibitor, and as the only insulin company exhibiting offline at the conference, it drew wide attention from industry experts. In addition, Gan & Lee Pharmaceuticals conducted several rounds of academic exchanges and interactions with global experts in the field of diabetes, and the event was a complete success.

In September 2022, Gan & Lee Pharmaceuticals participated in the 58th Annual European Association for the Study of Diabetes (EASD) Conference in Stockholm, Sweden. The conference, organized by the European Association for the Study of Diabetes, attracts leading physicians, scientists and healthcare professionals from around the world through a combination of online and offline formats, providing the medical community with an opportunity to learn about diabetes cutting-edge technologies, groundbreaking research findings and a significant advances in the direction of treatment and care. For the first time, Gan & Lee Pharmaceuticals met with global experts in the field of diabetes in the form of an offline exhibition for academic exchange and discussion at the EASD Annual Meeting.

American Diabetes Association’s 82nd Scientific Sessions took place on June 3-7, 2022 at the Ernest N. Morial Convention Center (MCCNO) in New Orleans, Louisiana, USA. Gan & Lee Pharmaceuticals had a presence via their exhibit at the Conference. The event attracted more than 8,000 top doctors, scientists and healthcare professionals from all over the world through a combination of online and offline attendance, focusing on the latest, cutting-edge advances in diabetes research, prevention and care.As the only Chinese exhibitor, Gan & Lee has participated in the ADA tradeshow in the past. Presenting at conferences such as the ADA paves the way for the later commercializaiton of our diabetes products in the US and the European markets.

The 79th American Diabetes Association Scientific Annual Conference (ADA) was held in San Francisco, USA in 2019. As the only Chinese pharmaceutical enterprise in China invited to participate, Gan & Lee Pharmaceuticals set up a booth, and participated in 180 conferences, including seminars...

The 20th CPhI was held at the Shanghai New International Expo Center, where Gan & Lee Pharmaceuticals built a 121㎡ booth. Through videos, product and poster display, brochures, and the application of corporate logo and material combination, Gan & Lee shared the corporate culture...

The 56th European Society for the Studies of Diabetes (EASD) Annual Meeting covers corporate satellite meetings, oral reports, poster presentations, abstract releases, expert speeches, and exhibitions. It attracted experts, doctors, medical practitioners, and the media globally...

The 24th National Academic Conference of Chinese Diabetes Society was held in Suzhou from November 25 to 27, 2020. The conference was held online and offline with strict control for Covid-19 pandemic. It was an academic event that integrates the latest developments in domestic academic research at the highest level...